# Phase I Study of the Safety, Tolerance, and Pharmacokinetics of FK463 in Immunocompromised Children With Fever and Neutropenia

> **NCT00001790** · PHASE1 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 120 (—)

## Conditions studied

- Fever
- Mycoses
- Neutropenia

## Interventions

- **DRUG:** FK463

## Key facts

- **NCT ID:** NCT00001790
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-10
- **Primary completion:** —
- **Final completion:** 2000-09
- **Target enrollment:** 120 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001790

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001790, "Phase I Study of the Safety, Tolerance, and Pharmacokinetics of FK463 in Immunocompromised Children With Fever and Neutropenia". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT00001790. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*